Dr. James Peter Basilion's research lab focuses on improving cancer treatment through innovative imaging and therapeutic techniques. By developing specialized agents that target cancer cells, they aim to enhance surgical precision while boosting the immune response to prevent recurrence and metastasis. Their work combines fluorescence-guided surgery with photodynamic and photothermal therapies to address unmet clinical needs in prostate and breast cancer treatments.

Dr. Ahmet Erdemir's lab focuses on improving the accuracy and consistency of knee biomechanics simulations. They work on developing standardized modeling workflows to ensure that simulations can reliably predict knee mechanics, which is important for understanding musculoskeletal diseases and improving surgical outcomes. The research aims to make computational models more accessible and reproducible, which can ultimately help in clinical decision-making and personalized medicine for patients with knee issues.

Dr. Agata Exner's research focuses on enhancing cancer diagnosis and treatment using innovative ultrasound technologies. By developing specialized nanoparticles called nanobubbles, her lab aims to improve prostate cancer biopsy accuracy and predict how well tumors will respond to nanoparticle-based chemotherapy. This work seeks to revolutionize personalized cancer therapy by providing real-time imaging methods to guide treatment decisions.

Dr. Christopher Flask's lab focuses on improving cancer diagnosis and treatment monitoring using advanced MRI techniques. By developing innovative methods such as Magnetic Resonance Fingerprinting (MRF), they aim to better measure tumor blood flow and acidity. Their research highlights the potential for these techniques to be translated into clinical settings for more effective cancer therapies.

Dr. William Grissom's lab focuses on developing innovative techniques for prostate cancer surgery to reduce complications associated with traditional invasive procedures. By integrating low-field MRI with a specialized robotic system, the lab aims to create a minimally invasive approach that allows surgeons to precisely target and remove cancerous tissue while preserving healthy tissue. This research can potentially revolutionize the treatment of prostate cancer, enhancing patient outcomes and quality of life.

The research lab of Dr. Shuo Li focuses on improving the prediction and management of heart failure through advanced imaging techniques. By analyzing non-contrast low-dose CT scans, the lab aims to develop machine learning models that can identify individuals at high risk of heart failure. The lab's work combines innovative radiomics with clinical health assessments, seeking to enhance preventive strategies and ensure more personalized patient care.

Dr. Michael Moffitt's lab at Case Western Reserve University focuses on using light to treat chronic pain through a technique called photobiomodulation (PBM). The lab investigates how specific wavelengths of light can temporarily block pain signals in nerves, exploring the underlying biological mechanisms and working towards developing implantable devices for clinical use. Their research aims to enhance understanding of nerve function and pain relief, ultimately contributing to better pain management therapies.

Dr. Efstathios Karathanasis's lab focuses on developing innovative nanoparticle-based therapies to improve cancer treatment, particularly for aggressive forms of the disease. The lab's research aims to reprogram the tumor microenvironment to enhance the immune response against tumors, using a combination of advanced nanoparticle techniques and immune system manipulation. By targeting specific immune checkpoints and using novel delivery methods, their work seeks to transform cancer immunotherapy and prevent tumor recurrence.

David Escobar Sanabria's research lab focuses on understanding Parkinson's disease by exploring how neural circuits in the brain affect movement control. By developing advanced tools that can modulate brain activity in real-time, the lab aims to improve treatments for Parkinson's and other neurological conditions. Specifically, they are investigating how certain brainwave patterns relate to motor symptoms and developing personalized therapeutic devices based on their findings.

Dr. Michael W. Jenkins' lab focuses on understanding how the nervous system controls the ocular surface, which is essential for maintaining eye health and function. The research involves studying the complex interactions between nerves, immune responses, and the structures of the eye, particularly in conditions that affect eye lubrication and sensation. By using advanced imaging techniques and animal models, the lab aims to uncover the underlying mechanisms of eye disorders and explore potential treatment options.

Dr. Jay L. Alberts and his research team study how different forms of aerobic exercise can help people with Parkinson's disease (PD). They investigate the effects of high-intensity exercise, particularly in community settings, and how genetics influence the effectiveness of these interventions. They also explore the neural mechanisms behind improvements from exercise, especially for advanced Parkinson's patients using deep brain stimulation. Their work aims to create personalized exercise recommendations to slow disease progression and improve the quality of life for those living with PD.

Dr. Leonardo Kayat Bittencourt's lab focuses on improving the detection of prostate cancer through advanced imaging techniques. Their key project involves developing a new MRI method called Magnetic Resonance Fingerprinting, which aims to provide faster and more accurate imaging of the prostate. This technology is designed to help avoid unnecessary biopsies for patients who are not at high risk of prostate cancer, ultimately improving patient care and reducing healthcare costs.

Dr. Margot S. Damaser’s lab focuses on developing innovative treatments for pelvic organ prolapse (POP), a condition that affects many women and can significantly impact their quality of life. The lab's main project investigates a novel drug delivery system using biodegradable nanomaterials to restore the elasticity of pelvic tissues, potentially preventing the progression of POP without invasive surgery. By combining advanced biomaterials with therapeutic agents, the lab aims to create effective and minimally invasive solutions for better women's health outcomes.

Dr. Yong Chen's lab focuses on improving cancer diagnosis and treatment monitoring using advanced MRI techniques, specifically Magnetic Resonance Fingerprinting (MRF). The lab aims to develop non-invasive methods for predicting treatment responses in breast cancer and characterizing renal cell carcinoma. By utilizing innovative imaging biomarkers, the research seeks to personalize and enhance patient care while reducing unnecessary procedures and associated healthcare costs.

Dr. Zheng-Rong Lu's lab focuses on creating advanced anticancer therapies specifically targeting pancreatic cancer. The team is developing innovative nanovaccines made from lipid nanoparticles that aim to enhance immunotherapy effectiveness against this aggressive cancer. By combining these nanovaccines with immune checkpoint inhibitors, the research seeks to significantly improve treatment outcomes for patients with pancreatic ductal adenocarcinoma, a disease known for its low survival rates.

Dr. Xin Yu's lab at Case Western Reserve University focuses on understanding and improving recovery after a stroke. The lab develops advanced MRI techniques to study how fluid moves in the brain and how a protein called AQP4 contributes to brain edema during stroke recovery. This research aims to provide new insights that could lead to better treatments for patients recovering from strokes.